Oncternal Therapeutics Inc
(ONCT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2008 | 12-2007 | 12-2006 | 12-2005 | 12-2004 | |
| Sales | 13,528 | 7,126 | 7,505 | 3,782 | 1,867 |
| Cost of Goods | 649 | 621 | 773 | 1,573 | N/A |
| Gross Profit | 12,879 | 6,505 | 6,732 | 2,209 | 1,867 |
| Operating Expenses | 68,048 | 52,630 | 46,022 | 41,341 | 25,161 |
| Operating Income | -54,520 | -45,504 | -38,517 | -38,559 | -23,294 |
| Other Income | 2,740 | 5,145 | 3,007 | 1,720 | 946 |
| Pre-tax Income | -51,780 | -40,359 | -35,510 | -36,839 | -22,348 |
| Net Income Continuous | -51,780 | -40,359 | -35,510 | -36,839 | -22,348 |
| Net Income | $-51,780 | $-40,359 | $-35,510 | $-36,839 | $-22,348 |
| EPS Basic Total Ops | -2,001.40 | -1,623.51 | -1,595.52 | -1,987.40 | -349.90 |
| EPS Basic Continuous Ops | -1,996.32 | -1,616.65 | -1,595.48 | -1,984.42 | -1,360.32 |
| EPS Diluted Total Ops | -2,001.40 | -1,623.51 | -1,595.52 | -1,987.40 | -1,301.61 |
| EPS Diluted Continuous Ops | -1,996.32 | -1,616.65 | -1,595.48 | -1,984.42 | -1,299.88 |
| EBITDA(a) | $-63,915 | $-50,404 | $-43,525 | $-38,858 | $-23,874 |